openPR Logo
Press release

Multiplex Assays Market Showing Impressive Growth during Forecast Period 2021 - 2031 | Luminex Corporation, Thermo Fisher Scientific Inc, Illumina Inc

09-14-2023 09:36 PM CET | Health & Medicine

Press release from: Global Insight Services

Multiplex Assays Market Showing Impressive Growth during

New York, A multiplex assay is a type of biochemical test that can measure multiple analytes in a single sample. This assay is often used in medical and research laboratories to measure the levels of multiple proteins, hormones, or other biomolecules in a single patient or subject. Multiplex assays can also be used to measure the levels of multiple genes or gene products in a single sample of cells or tissue.

Download a Free PDF Sample Copy of Report - https://www.globalinsightservices.com/request-sample/GIS20762/

Key Players

The global multiplex assays market includes players such as Luminex Corporation, Thermo Fisher Scientific Inc, Illumina Inc, Bio-Rad Laboratories Inc, QIAGEN N.V., Becton Dickinson and Company, Abcam PLC, Seegene Inc., Meso Scale Diagnostics LLC, Randox Laboratories Ltd, and others.

Read more about Multiplex Assays Market here: https://www.globalinsightservices.com/reports/multiplex-assays-market/

Key Trends

The key trends in Multiplex Assays technology are miniaturization, portability, and automation.

Miniaturization refers to the ability to reduce the size of the assay while maintaining its accuracy and precision. This is achieved by using smaller reagents and smaller reaction vessels.

Portability refers to the ability to perform the assay anywhere, anytime. This is achieved by using portable devices such as handheld devices and microfluidic devices.

Automation refers to the ability to automate the entire assay process, from sample preparation to data analysis. This is achieved by using automated instruments and software.

Key Drivers

The key drivers of the Multiplex Assays market are the increasing demand for early and accurate diagnosis of diseases, the rising prevalence of chronic diseases, and the growing need for personalized medicine.

Other drivers include the increasing investment in R&D by pharmaceutical and biotechnology companies, the growing demand for personalized medicine, and the increasing number of clinical trials.

Get Customized report as per your requirements - https://www.globalinsightservices.com/request-customization/GIS20762/

Market Segment

By Technology

-Flow Cytometry
-Fluorescence Detection
-Luminescence
-Others

By Application

-Research and Development
-Clinical Diagnostics

By End-Use

-Pharmaceutical Companies
-Hospitals
-Reference Laboratories
-Others

Buy your copy now: https://www.globalinsightservices.com/checkout/single_user/GIS20762/

With Global Insight Services, you receive:
- 10-year forecast to help you make strategic decisions
- In-depth segmentation which can be customized as per your requirements
- Free consultation with lead analyst of the report
- Excel data pack included with all report purchases
- Robust and transparent research methodology

Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/

About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Multiplex Assays Market Showing Impressive Growth during Forecast Period 2021 - 2031 | Luminex Corporation, Thermo Fisher Scientific Inc, Illumina Inc here

News-ID: 3208956 • Views:

More Releases from Global Insight Services

Immuno Oncology Drugs Market Projected to Reach $634.1 Billion by 2034, Growing at 17.5% CAGR | Overall Study Report
Immuno Oncology Drugs Market Projected to Reach $634.1 Billion by 2034, Growing …
The Immuno Oncology Drugs Market is rapidly emerging as a transformative segment in the global healthcare industry. These drugs harness the body's immune system to identify and attack cancer cells, offering innovative treatment alternatives to traditional chemotherapy and radiation therapies. Immuno-oncology therapies include monoclonal antibodies, checkpoint inhibitors, cancer vaccines, and cell-based therapies such as CAR-T cells. The growth of this market is primarily driven by advancements in biotechnology, an improved
GLP 1 Market Projected to Reach $221.8 Billion by 2034, Growing at 9% CAGR | Overall Study Report
GLP 1 Market Projected to Reach $221.8 Billion by 2034, Growing at 9% CAGR | Ove …
The GLP 1 Market is experiencing unprecedented growth, fueled by the rising prevalence of type 2 diabetes and obesity globally. GLP-1, or glucagon-like peptide-1 receptor agonists, represents a groundbreaking therapeutic class that improves insulin secretion, reduces glucagon production, and slows gastric emptying. These mechanisms not only enhance glycemic control but also support weight management, making GLP-1 therapies a preferred choice among healthcare providers and patients alike. Over the years, the
Autonomous Bus Market to Expand to $11.6 Billion by 2034, Advancing at 18.8% CAGR | Key Players: EasyMile, Navya, Aurrigo
Autonomous Bus Market to Expand to $11.6 Billion by 2034, Advancing at 18.8% CAG …
Market Overview Autonomous Bus Market is revolutionizing the future of urban mobility through advanced automation technologies. Valued at $2.1 billion in 2024, the market is projected to reach $11.6 billion by 2034, expanding at a strong CAGR of 18.8%. This market focuses on the development and deployment of self-driving buses equipped with cutting-edge sensors, artificial intelligence, and vehicle-to-everything (V2X) communication systems. These buses are designed to improve road safety, enhance passenger
Automotive Tire Market to Attain $976.7 Billion by 2034, Growing at 9.2% CAGR | Key Players: Apollo Tyres, Nokian Tyres, Hankook Tire
Automotive Tire Market to Attain $976.7 Billion by 2034, Growing at 9.2% CAGR | …
Market Overview Automotive Tire Market is experiencing remarkable growth as the industry embraces innovation, sustainability, and digital transformation. Valued at $406 billion in 2024, the market is projected to soar to $976.7 billion by 2034, reflecting a CAGR of 9.2%. This expansion is primarily driven by the surge in global vehicle production, growing consumer preference for durable and high-performance tires, and the increasing adoption of smart tire technologies. The Automotive Tire

All 5 Releases


More Releases for Multiplex

Recliners India Unveils Luxury Multiplex Recliners at Rathindra Multiplex in Kol …
Press release-Kolkata, India - Sep 29, 2025 - Recliners India, a leading name in premium cinema seating, is proud to announce the grand opening of Rathindra Multiplex in Kolkata, where every seat showcases our state-of-the-art multiplex recliners and sofa sliders. As the exclusive manufacturer and installer of all seating at this stunning new cinema, we're elevating Kolkata's vibrant film scene with unmatched comfort and style, redefining how moviegoers enjoy their
Transformative Trends Impacting the Multiplex Biomarker Imaging Market Landscape …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Multiplex Biomarker Imaging Market Size By 2025? In recent times, the size of the multiplex biomarker imaging market has experienced significant growth. There is an expected rise from $0.49 billion in 2024 to $0.54 billion in 2025, with a compound annual growth rate (CAGR) of
Key Trends Shaping the Future Multiplex Biomarker Imaging Market From 2025-2034: …
What Is the Estimated Market Size and Growth Rate for the Multiplex Biomarker Imaging Market? In recent times, the market size for multiplex biomarker imaging has experienced significant growth. Forecasts predict that it will expand from $0.49 billion in 2024 to $0.54 billion in 2025, representing a compound annual growth rate (CAGR) of 11.0%. Factors contributing to this historic growth include the rising cancer rates, the demand for accurate diagnostic instruments,
Multiplex Biomarker Imaging: Enhancing Diagnostics in 2024
The Business Research Company recently released a comprehensive report on the Global Multiplex Biomarker Imaging Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. Ready to Dive into Something Exciting? Get Your
Multiplex Detection Immunoassay Market Report 2030
Multiplex detection immunoassays are spearheading a revolution in diagnostics, enabling the simultaneous detection of multiple biomarkers in a single assay. With the market projected to reach USD 3,704.9 million by 2030 from USD 1,781.6 million in 2021, these advanced tools are proving indispensable in both research and clinical settings, offering comprehensive insights into biological processes and aiding in disease diagnosis and monitoring. Download Sample Report Copy Of This Report From Here:
Multiplex Assays Market Size and Trends
According to a new market research report published by Global Market Estimates, the Global Multiplex Assays Market is projected to grow at a CAGR value of 9.2% from 2023 to 2028. The market for multiplex assays is fueled by factors including the rising desire for quicker and more effective diagnostic solutions. Through the simultaneous detection and analysis of numerous analytes in a single sample, multiplex assays provide speedier and more thorough